Novel vitamin E intermediates and process for the preparation of (2R, 4'RS)- alpha -tocopherol and (all-rac)- alpha -tocopherol via the novel intermediates

    公开(公告)号:DE3322995A1

    公开(公告)日:1983-12-29

    申请号:DE3322995

    申请日:1983-06-25

    Applicant: BASF AG

    Abstract: Compounds of the general formula I in which R denotes H, an alkyl radical, arylalkyl radical or an aliphatic acyl radical, preferably a benzyl group or acetyl group, and Y represents OH and X represents H (Ia) or else X and Y together represent a further bond between the C atoms carrying X and Y (Ib) and the dashed line may denote an additional bond, in particular [2R,1'Z,3'E,7'E]-6-benzyloxy-2,5,7,8-tetramethyl-2-(4',8',12'- trimethyltrideca-1',3',7'-trien-1'-yl)chroman and 6-benzyloxy-2,5,7,8- tetramethyl-2-(1'-hydroxy-4',8',12'-trimethyltrideca-3',7'-dien-1-yl)- chroman, and compounds of the general formula II in which Z represents one of the groups ClMg-; BrMg- (IIa); CL ; BR - (IIb> in which R represents alkyl having 1 to 4 C atoms, in particular (3,7,11-trimethyltrideca-2,6,10-trien-1-yl)triphenylphosphonium chloride and dimethyl (3,7,11-trimethyltrideca-2,6,10-trien-1-yl)- phosphite. The invention furthermore relates to a process for the preparation of (2R,4'RS,8'RS)- alpha -tocopherol or (all-rac)- alpha -tocopherol, starting from the compounds of the formula II and via the compounds of the formula I.

    3.
    发明专利
    未知

    公开(公告)号:DE3030054A1

    公开(公告)日:1982-03-25

    申请号:DE3030054

    申请日:1980-08-08

    Applicant: BASF AG

    Abstract: A process for the preparation of N-(D)-ribityl-2-phenylazo-4,5-dimethylaniline (I), wherein 1. in the case of pure or virtually pure (D)-ribose (III) (a) the latter is reacted with 3,4-dimethylnitrobenzene (IVa) or 3,4-dimethylaniline (IVb) and with hydrogen in the presence of a hydrogenation catalyst, (b) the resulting solution is reacted, in a conventional manner, with an acid phenyldiazonium salt solution (VI) and (c) the resulting product is isolated by crystallization, in a conventional manner, or 2. in the case of crude ribose, ie. industrial mixtures of (D)-ribose and other sugars (a) the crude ribose is reacted with about equimolar amounts, based on III, of 3,4-dimethylaniline (IVb) and boric acid, (b) the boric acid ester of the Schiff base obtained from III and IVb is allowed to crystallize out and is separated off, (c) this ester is hydrogenated with hydrogen in the presence of a hydrogenation catalyst, (d) the solution is freed from catalyst and reacted, in a conventional manner, with an acid phenyldiazonium salt solution and (e) the resulting product I is isolated by crystallization in a conventional manner.

    5.
    发明专利
    未知

    公开(公告)号:DE2842715A1

    公开(公告)日:1980-04-10

    申请号:DE2842715

    申请日:1978-09-30

    Applicant: BASF AG

    Abstract: 3-Chloro-3-methyl-butane-1,4-dial-bis-acetals and 3-methyl-but-2-ene-1,4-dial-bis-acetals are obtained by reacting a six-membered cyclic acetal of 3-methyl-but-3-en-1-al with an alkyl nitrite in the presence of methanol and hydrogen chloride and, if desired, eliminating HCl in the conventional manner. The butanedial-bis-acetals and butenedial-bis-acetals are valuable intermediates through which the trans-3-methyl-but-2-ene-1,4-dial-1-acetals, which are sought-after products for terpene syntheses, can be obtained in an industrially particularly advantageous manner.

    Novel optically active halogenated hydrocarbons, their preparation and their use as intermediates for the synthesis of (R,R,R)- alpha -tocopherol

    公开(公告)号:DE3145454A1

    公开(公告)日:1983-05-26

    申请号:DE3145454

    申请日:1981-11-16

    Applicant: BASF AG

    Abstract: 1-Bromo-4-chloro-2-methylbutane, (S)-1-bromo-4-chloro- 2-methylbutane (V) and (R)-5-chloro-3-methylpentanoic acid (Va) and the use of (S)-3-methylvalerolactone, (S)-1-bromo-4-chloro- 2-methylbutane (V) or (R)-5-chloro-3-methylpentanoic acid (Va) as optically active intermediates for the synthesis of the side chain of (R,R,R)- alpha -tocopherol and a process for the preparation of (3R,7R)-1-chloro-3,7,11-trimethyldodecane of the formula Ia in which n is 1, characterised in that A) (S)-3-methylvalerolactone of the formula IV is cleaved using liquid hydrogen chloride at 100 to 170 DEG C in a pressurised vessel to give the novel (3R)-5-chloro-3-methylpentanoic acid of the formula Va B) this acid is converted in a manner known per se into the novel dihalide of the formula IIa in which X represents Br or I, by decarboxylation with bromine or iodine, and C) this dihalide is reacted in the presence of copper ions with an organomagnesium compound of the formula IIIa in which Y represents Cl, Br or I and n represents 1, at temperatures below 0 DEG C in an ether solvent, preferably tetrahydrofuran.

Patent Agency Ranking